AI assistant
MACQUARIE TECHNOLOGY GROUP LIMITED — Director's Dealing 2025
Apr 6, 2025
65295_rns_2025-04-06_c75664d1-da9f-45a3-86ff-1171ba848e1c.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Macquarie Technology Group Limited ABN 72 056 712 228
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Peter James |
|---|---|
| Date of last notice | 10 March 2025 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Indirect |
|---|---|
| Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest. |
Ordinary shares held by Christie James Funds Management Pty Ltd as trustee for Christie James Superannuation Fund (ACN 908 492 215). Mr James is a Director of Christie James Funds Management Pty Ltd and a beneficiary of Christie James Superannuation Fund. |
| Date of change | 31 March 2025 and 2 April 2025 |
| No. of securities held prior to change | 23,950 |
| Class | Fully paid ordinary shares |
| Number acquired | N/A |
| Number disposed | N/A |
| Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation |
N/A |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| No. of securities held after change | 23,950 fully paid ordinary shares: • 11,064 held by Christie James Funds Management Pty Ltd as trustee for the Christie James Superannuation Fund; • 6,443 held by James Christie No. 2 Pty Ltd as trustee for the Peter and Sophie Testamentary Trust; and • 6,443 held by James Christie No. 1 Pty Ltd as trustee for the Peter and Simon Testamentary Trust. Mr Peter James is a director of Christie James Funds Management Pty Ltd, James Christie No. 2 Pty Ltd and James Christie No. 1 Pty Ltd, and is a beneficiary of Christie James Superannuation Fund, Peter and Sophie Testamentary Trust and Peter and Simon Testamentary Trust. |
|---|---|
| Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back |
Off market trade |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
Detail of contract Nature of interest Name of registered holder (if issued securities) Date of change N/A No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed Interest acquired Interest disposed Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Interest after change N/A
Part 3 –[+] Closed period
| Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required? |
No |
|---|---|
| If so, was prior written clearance provided to allow the trade to proceed during this period? |
N/A |
| If prior written clearance was provided, on what date was this provided? |
N/A |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3